Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms, Finnish Researchers, Japan's Riken Partner on COVID-19 Risk Assessment

NEW YORK – BC Platforms said Tuesday that it has entered into a collaboration with Japanese research institute Riken and the Finnish Institute for Health and Welfare (known by Finnish acronym THL) to build a predictive model to identify people's risk for contracting COVID-19.

The organizations will work together to apply artificial intelligence in an effort to understand genomic and phenotypic associations with the infectious disease. They will seek to determine why and how the SARS-CoV-2 coronavirus is deadly for some patients and not others.

This effort will apply AI-based disease stratification algorithms from Riken to samples and data from COVID-19-positive patients in Finland within THL's national COVIDprog research project. BC Platforms will offer its BC|Insight data collection platform to curate, integrate, and analyze clinical data from as many as 1,000 COVIDprog participants.

"Our hope is, together, we will gain insights into exactly who is at risk from COVID-19, and why, at a molecular/genetic level, so society can better allocate resources to those who most need them to survive the pandemic," Markus Perola, leader of the COVIDprog research at THL, said in a statement.

"Systematic data sharing in a safe and secure manner is crucial in our fight against COVID-19," added BC Platforms CEO Tero Silvola. "We are looking forward to working with Riken to make this AI prediction platform available to other healthcare systems in order to help them to fight the COVID-19 pandemic."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.